The potential of the novel NAD+ supplementing agent, SNH6, as a therapeutic strategy for the treatment of Friedreich’s ataxia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The potential of the novel NAD+ supplementing agent, SNH6, as a therapeutic strategy for the treatment of Friedreich’s ataxia

Published:2020-05 Issue: Volume:155 Page:104680
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Chiang Shannon,Kalinowski Danuta S.,Dharmasivam Mahendiran,Braidy Nady,Richardson Des R.,Huang Michael L.H.

Funder

Muscular Dystrophy Association USA for a Development Grant

National Health and Medical Research Council of Australia

.R.R. D.R.R. appreciates an NHMRC Senior Principal Research Fellowship

NHMRC Career Development Fellowship

University of Sydney DVC Research Bridging Fellowship and Cancer Institute NSW Career Development Fellowship

Publisher

Elsevier BV

Subject

Pharmacology

Reference91 articles.

1. Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol;Richardson;Proc. Natl. Acad. Sci. U. S. A.,2010

2. Friedreich’s ataxia: iron chelators that target the mitochondrion as a therapeutic strategy?;Richardson;Expert Opin. Investig. Drugs,2003

3. Therapeutic approaches for the treatment of Friedreich’s ataxia;Strawser;Expert Rev. Neurother.,2014

4. Elucidation of the mechanism of mitochondrial iron loading in Friedreich’s ataxia by analysis of a mouse mutant;Huang;Proc. Natl. Acad. Sci. U. S. A.,2009

5. The ins and outs of mitochondrial iron-loading: the metabolic defect in Friedreich’s ataxia;Richardson;J. Mol. Med.,2010

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The mechanism of ferroptosis and its related diseases;Molecular Biomedicine;2023-10-16

2. Omaveloxolone: an activator of Nrf2 for the treatment of Friedreich ataxia;Expert Opinion on Investigational Drugs;2023-01-02

3. An Understanding of Different Mechanisms Leading to Neurodegenerative Diseases;Handbook of Neurodegenerative Disorders;2023

4. Mechanisms of impaired mitochondrial homeostasis and NAD+ metabolism in a model of mitochondrial heart disease exhibiting redox active iron accumulation;Redox Biology;2021-10

5. Treatment of dilated cardiomyopathy in a mouse model of Friedreich’s ataxia using N-acetylcysteine and identification of alterations in microRNA expression that could be involved in its pathogenesis;Pharmacological Research;2020-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3